Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us

Non-Plasmin Proteases as Destabilizers of Fibrin Based Scaffolds

Graduate #2
Discipline: Biological Sciences
Subcategory: Biomedical Engineering

Simone Douglas - Georgia Institute of Technology
Co-Author(s): Sarah E. Lamothe, Georgia Institute of Technology, GA; Tatiyanna S. Singleton, Georgia Institute of Technology, GA; Rodney Averett, University of Georgia, GA; Manu O. Platt Georgia Institute of Technology, GA



Fibrin-based constructs are favored due to proangiogenic properties, and controllable gelation time and network geometry, making fibrin a promising scaffold for tissue engineered systems in regenerative medicine. Proteolytic activity is needed for matrix remodeling during tissue engineered construct development, however, uncontrolled proteolysis could lead to their destabilization. Tissue destructive mechanisms due to fibrin degradation should be considered, even in the absence of plasmin, the canonical fibrinolytic enzyme. Cell types in these constructs could synthesize matrix depositing non-plasmin proteases leading to destabilization due to fibrin degradation. We hypothesize that cysteine cathepsins, powerful proteases first identified in lysosomes, but now known to be secreted by several cell types in tissue destructive disease progression, can hydrolyze fibrin(ogen) and destabilize fibrin-based constructs. Identification of cathepsin-mediated fibrin degradation, an undetermined mechanism in biology, will allow for improved inhibitory design strategies to sustain stability in fibrin-based tissue engineered constructs. Fibrin gels were polymerized by combining fibrinogen and thrombin, then incubated with increasing amounts of recombinant cathepsins (cat) K, L, or S, or plasmin as a control, for 24 hours. Soluble fraction, containing released fragments, and insoluble fraction, containing fibrin gel, were collected and prepared for reduced SDS-PAGE and multiplex cathepsin zymography to assess fibrin degradation, and amounts of active cathepsins, respectively. CatK, catL, and catS all degraded fibrin as indicated by loss of the α, β or γ fibrin chain in the PAGE as protease concentration increases compared to the no enzyme control. However, we determined catL is associated with fibrin degradation products as it degrades the fibrin gel, as indicated by active catL higher molecular weight bands (37-75 kDa) which correlate with degraded α, β or γ fibrin chains. We hypothesize that fibrin acts as a reservoir for catL, which may serve to stabilize and sustain its activity in the system, allowing it to further degrade fibrin fragments in the soluble fraction. Thus, in fibrin-based constructs catL can be bound to fibrin and fibrin fragments maintaining its fibrinolytic activity, which explains a mechanism for why constructs will continue to fail. CatS only yielded a zymogram active signal at the free catS size (25kDa) and catK yielded no zymogram active signal after the incubation period. These studies demonstrate that catK, L, and S are fibrinolytic, and specifically degrade fibrin polypeptide chains, in cleavage patterns that differ from plasmin. We are investigating if catS has the greatest fibrinolytic capabilities compared to catK or L by kinetic studies, and are modifying our zymography protocol to include fibrinogen as the in situ substrate, to demonstrate directly fibrinolysis by cathepsins. This will motivate the inclusion of cathepsin regulatory and inhibitory strategies in the design of fibrin-based tissue engineered constructs, while also generating new hypotheses for abnormal cathepsin-based fibrinolysis in the fields of thrombosis and hemostasis.

SDouglas_ERN Conference Abstract.docx

Funder Acknowledgement(s): Emergent Behavior of Integrated Cellular Systems (EBICS)- NSF STC ; NSF Graduate Research Fellowships

Faculty Advisor: Manu O. Platt, manu.platt@bme.gatech.edu

Role: Experimental design; all experiments, assays, and data analysis

ERN Conference

The 2022 ERN Conference has been postponed.

Full Notice

What’s New

  • Congratulations to Zakiya Wilson-Kennedy on her 2021 AAAS Fellowship
  • Event Vaccination and Liability Policy
  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2022 American Association for the Advancement of Science